DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,042 filers reported holding DANAHER CORPORATION in Q1 2016. The put-call ratio across all filers is 0.83 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $824,000 | +3.1% | 3,710 | 0.0% | 0.40% | -0.7% |
Q3 2020 | $799,000 | +21.8% | 3,710 | 0.0% | 0.40% | +27.1% |
Q2 2020 | $656,000 | +27.9% | 3,710 | 0.0% | 0.32% | +27.3% |
Q1 2020 | $513,000 | -9.8% | 3,710 | 0.0% | 0.25% | +29.7% |
Q4 2019 | $569,000 | -1.6% | 3,710 | -7.2% | 0.19% | -3.0% |
Q3 2019 | $578,000 | +1.0% | 4,000 | 0.0% | 0.20% | -2.5% |
Q2 2019 | $572,000 | +8.3% | 4,000 | 0.0% | 0.20% | +3.6% |
Q1 2019 | $528,000 | +28.2% | 4,000 | 0.0% | 0.20% | +17.4% |
Q4 2018 | $412,000 | -5.3% | 4,000 | 0.0% | 0.17% | +5.0% |
Q3 2018 | $435,000 | +10.1% | 4,000 | 0.0% | 0.16% | +3.9% |
Q2 2018 | $395,000 | +0.8% | 4,000 | 0.0% | 0.15% | +9.3% |
Q1 2018 | $392,000 | +5.7% | 4,000 | 0.0% | 0.14% | +15.7% |
Q4 2017 | $371,000 | +8.2% | 4,000 | 0.0% | 0.12% | +5.2% |
Q3 2017 | $343,000 | +1.5% | 4,000 | 0.0% | 0.12% | -4.2% |
Q2 2017 | $338,000 | -1.2% | 4,000 | 0.0% | 0.12% | -3.2% |
Q1 2017 | $342,000 | +10.0% | 4,000 | 0.0% | 0.12% | +7.8% |
Q4 2016 | $311,000 | -1.0% | 4,000 | 0.0% | 0.12% | -8.0% |
Q3 2016 | $314,000 | -22.3% | 4,000 | 0.0% | 0.12% | -22.8% |
Q2 2016 | $404,000 | +6.6% | 4,000 | 0.0% | 0.16% | +1.9% |
Q1 2016 | $379,000 | +1.9% | 4,000 | 0.0% | 0.16% | +0.6% |
Q4 2015 | $372,000 | +9.1% | 4,000 | 0.0% | 0.16% | +2.6% |
Q3 2015 | $341,000 | -0.3% | 4,000 | 0.0% | 0.15% | +7.7% |
Q2 2015 | $342,000 | +0.6% | 4,000 | 0.0% | 0.14% | 0.0% |
Q1 2015 | $340,000 | -0.9% | 4,000 | 0.0% | 0.14% | +0.7% |
Q4 2014 | $343,000 | +12.8% | 4,000 | 0.0% | 0.14% | +6.8% |
Q3 2014 | $304,000 | -3.5% | 4,000 | 0.0% | 0.13% | -2.2% |
Q2 2014 | $315,000 | +5.0% | 4,000 | 0.0% | 0.14% | +3.0% |
Q1 2014 | $300,000 | -2.9% | 4,000 | 0.0% | 0.13% | -4.3% |
Q4 2013 | $309,000 | +11.6% | 4,000 | 0.0% | 0.14% | 0.0% |
Q3 2013 | $277,000 | +9.5% | 4,000 | 0.0% | 0.14% | +5.3% |
Q2 2013 | $253,000 | – | 4,000 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |